Double‐blind randomized controlled clinical trial of the interleukin‐6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
Maini, R. N., Taylor, P. C., Szechinski, J., Pavelka, K., Bröll, J., Balint, G., Emery, P., Raemen, F., Petersen, J., Smolen, J., Thomson, D., Kishimoto, T.
Published in Arthritis and rheumatism (01.09.2006)
Published in Arthritis and rheumatism (01.09.2006)
Get full text
Journal Article